Itai Danovitch, ITAI, Danovitch

Itai Danovitch practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Itai Danovitch's NPI, 1457575169, was assigned on April 12, 2007. Itai Danovitch graduated from David Geffen School of Medicine at UCLA in 2003. Itai Danovitch holds California license A99119.

Itai Danovitch's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Itai Danovitch's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Itai Danovitch to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Itai Danovitch practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Itai Danovitch's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Itai Danovitch is board certified in addiction psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Itai Danovitch's licenses on file in 2 states: California and New York.

CMS data shows 45 Medicare services from Itai Danovitch across 2 procedure codes in 2024, for 28 Medicare patients. Medicare paid $4,103 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 28 Medicare patients who saw Itai Danovitch in 2024. 75% of them have anxiety, and 75% have depression. 54% are also on Medicaid. Their average risk score is 2.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Itai Danovitch's median patient age at 49, with 31% women.

In 2024, Itai Danovitch wrote 16 Medicare Part D claims. 100% of them were for generic drugs. They cover 3 drugs, with $287 in total drug cost. In 2018, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Itai Danovitch for performance year 2024, reported as part of a group. Itai Danovitch accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Itai Danovitch, published from 2012 to 2024. 2016 was the busiest year, with 3. The most frequent topics are Depression and Heart Failure. Itai Danovitch's most frequent co-authors are Waguih Ishak, MD, Michele Ann Hamilton, MD and John Gordon Harold, MD.

Dmand AI links Itai Danovitch to 3 clinical trials. Conditions studied include Behavior, Addictive, Compulsive Behavior and Depression. Cedars-Sinai Medical Center sponsors the most, 2.

Itai Danovitch graduated from David Geffen School of Medicine at UCLA in 2003. Itai Danovitch is a member of ASAM.

Itai Danovitch is in network with 5 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.